Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
Clinical trial NCT00849251 · TERMINATED
Trial details
- NCT number
- NCT00849251
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.